CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Roma, RM, Italy and 66 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Rome, Italy and 59 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Roma, Lazio, Italy and 215 other locations
Prospective, multicenter, open label, phase III randomized clinical trial in previously untreated Follicular Lymphoma in early stage. Patien...
Phase 3
Roma, Italy and 47 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Roma, Italy and 94 other locations
The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length...
Phase 3
Roma, Lazio, Italy and 34 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Roma, Italy and 73 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Rome, Lazio, Italy and 64 other locations
New Zealand, in elderly patients with untreated diffuse large B-cell lymphoma. Elderly is defined as either ≥80 years of age, or ≥75 years a...
Phase 3
Roma, Italy and 69 other locations
The purpose of this study is to define the objective response rates (ORR) of Lorlatinib in subjects with ALK+ lymphomas resistant or refract...
Phase 2
Roma, Italy and 1 other location
Clinical trials
Research sites
Resources
Legal